Tandem Diabetes Care Gets FDA Clearance For T:flex Insulin Pump - Quick Facts

(RTTNews) - Tandem Diabetes Care Inc. (TNDM) said that the U.S. Food and Drug Administration or FDA has granted the Company clearance to market the t:flex Insulin Pump. At 480 units, the insulin reservoir of the t:flex Pump has the largest capacity currently available in the United States.

People with diabetes require different amounts of insulin based on their level of insulin sensitivity, which can vary significantly from person to person. The t:flex Pump is designed for people who require more than 100 units of U-100 insulin per day, such as teenagers with type 1 diabetes and many people with type 2 diabetes.

The t:flex Pump is expected to launch in the United States in the second quarter of 2015.